Literature DB >> 35322398

Visualizing Opioid-Use Variation in a Pediatric Perioperative Dashboard.

Conrad W Safranek1, Lauren Feitzinger2, Alice Kate Cummings Joyner2, Nicole Woo2,3, Virgil Smith2, Elizabeth De Souza4, Christos Vasilakis5, Thomas Anthony Anderson4, James Fehr4, Andrew Y Shin6, David Scheinker2, Ellen Wang4, James Xie4.   

Abstract

BACKGROUND: Anesthesiologists integrate numerous variables to determine an opioid dose that manages patient nociception and pain while minimizing adverse effects. Clinical dashboards that enable physicians to compare themselves to their peers can reduce unnecessary variation in patient care and improve outcomes. However, due to the complexity of anesthetic dosing decisions, comparative visualizations of opioid-use patterns are complicated by case-mix differences between providers.
OBJECTIVES: This single-institution case study describes the development of a pediatric anesthesia dashboard and demonstrates how advanced computational techniques can facilitate nuanced normalization techniques, enabling meaningful comparisons of complex clinical data.
METHODS: We engaged perioperative-care stakeholders at a tertiary care pediatric hospital to determine patient and surgical variables relevant to anesthesia decision-making and to identify end-user requirements for an opioid-use visualization tool. Case data were extracted, aggregated, and standardized. We performed multivariable machine learning to identify and understand key variables. We integrated interview findings and computational algorithms into an interactive dashboard with normalized comparisons, followed by an iterative process of improvement and implementation.
RESULTS: The dashboard design process identified two mechanisms-interactive data filtration and machine-learning-based normalization-that enable rigorous monitoring of opioid utilization with meaningful case-mix adjustment. When deployed with real data encompassing 24,332 surgical cases, our dashboard identified both high and low opioid-use outliers with associated clinical outcomes data.
CONCLUSION: A tool that gives anesthesiologists timely data on their practice patterns while adjusting for case-mix differences empowers physicians to track changes and variation in opioid administration over time. Such a tool can successfully trigger conversation amongst stakeholders in support of continuous improvement efforts. Clinical analytics dashboards can enable physicians to better understand their practice and provide motivation to change behavior, ultimately addressing unnecessary variation in high impact medication use and minimizing adverse effects. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35322398      PMCID: PMC8942721          DOI: 10.1055/s-0042-1744387

Source DB:  PubMed          Journal:  Appl Clin Inform        ISSN: 1869-0327            Impact factor:   2.342


  29 in total

Review 1.  Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review.

Authors:  E Maund; C McDaid; S Rice; K Wright; B Jenkins; N Woolacott
Journal:  Br J Anaesth       Date:  2011-02-01       Impact factor: 9.166

2.  Quality Initiative Using Theory of Change and Visual Analytics to Improve Controlled Substance Documentation Discrepancies in the Operating Room.

Authors:  Jenny E Dolan; Hannah Lonsdale; Luis M Ahumada; Amish Patel; Jibin Samuel; Ali Jalali; Jacquelin Peck; JoAnn C DeRosa; Mohamed Rehman; Anna M Varughese; Allison M Fernandez
Journal:  Appl Clin Inform       Date:  2019-07-31       Impact factor: 2.342

Review 3.  Enhanced Recovery After Surgery: A Review.

Authors:  Olle Ljungqvist; Michael Scott; Kenneth C Fearon
Journal:  JAMA Surg       Date:  2017-03-01       Impact factor: 14.766

4.  The sustainability of a quality improvement initiative.

Authors:  Veronica Belostotsky; Catherine Laing; Deborah E White
Journal:  Healthc Manage Forum       Date:  2020-04-06

5.  Perioperative Opioid Use Predicts Postoperative Opioid Use and Inferior Outcomes After Shoulder Arthroscopy.

Authors:  Yining Lu; Alexander Beletsky; Matthew R Cohn; Bhavik H Patel; Jourdan Cancienne; Michael Nemsick; William K Skallerud; Adam B Yanke; Nikhil N Verma; Brian J Cole; Brian Forsythe
Journal:  Arthroscopy       Date:  2020-06-04       Impact factor: 4.772

6.  Visualization of aggregate perioperative data improves anesthesia case planning: A randomized, cross-over trial.

Authors:  Jonathan P Wanderer; Thomas A Lasko; Joseph R Coco; Leslie C Fowler; Matthew D McEvoy; Xiaoke Feng; Matthew S Shotwell; Gen Li; Brian J Gelfand; Laurie L Novak; David A Owens; Daniel V Fabbri
Journal:  J Clin Anesth       Date:  2020-11-01       Impact factor: 9.452

7.  The Society for Pediatric Anesthesia recommendations for the use of opioids in children during the perioperative period.

Authors:  Joseph P Cravero; Rita Agarwal; Charles Berde; Patrick Birmingham; Charles J Coté; Jeffrey Galinkin; Lisa Isaac; Sabine Kost-Byerly; David Krodel; Lynne Maxwell; Terri Voepel-Lewis; Navil Sethna; Robert Wilder
Journal:  Paediatr Anaesth       Date:  2019-06-11       Impact factor: 2.556

Review 8.  Opioid-sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children.

Authors:  Ivan Wong; Celia St John-Green; Suellen M Walker
Journal:  Paediatr Anaesth       Date:  2013-04-09       Impact factor: 2.556

9.  Development, implementation and preliminary evaluation of clinical dashboards in a department of anesthesia.

Authors:  Géry Laurent; Mouhamed D Moussa; Cédric Cirenei; Benoît Tavernier; Romaric Marcilly; Antoine Lamer
Journal:  J Clin Monit Comput       Date:  2020-05-16       Impact factor: 2.502

10.  A machine learning-based clinical decision support system to identify prescriptions with a high risk of medication error.

Authors:  Jennifer Corny; Asok Rajkumar; Olivier Martin; Xavier Dode; Jean-Patrick Lajonchère; Olivier Billuart; Yvonnick Bézie; Anne Buronfosse
Journal:  J Am Med Inform Assoc       Date:  2020-11-01       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.